Training Machine Learning Prediction of Antibody Thermostability Utilizing PROPERMAB Features and the GDPa4 Dataset

Antibody drug development is a years-long, costly process. Antibody thermostability is one of the key developability features of an antibody drug that influences its chances of success in development. But, experimental testing such as nanoDSF for large libraries of candidates requires substantial resources. Instead, we evaluated an open-source feature-based machine learning workflow to train a model for antibody stability (Tm1) predictions from sequence and structure-based features. We used PROPERMAB to extract features from a selection of 231 different monoclonal and bispecific antibodies from the GDPa4 nanoDSF dataset. We benchmarked regression and classification models that predict the median first thermal transition temperature (Tm1) from PTS-IF in degrees Celsius for antibodies in the GDPa4 data set from Gingko Datapoints. We trained the models on 184 antibodies and evaluated model performance on 47 held-out antibodies. The three different regression models were ElasticNet, RandomForest, and GradientBoosting. RandomForest achieved the highest reported correlations among the regressors (Pearson r = 0.750, R2 = 0.562). Performance was also evaluated relative to 66.29 degrees Celsius as the threshold for thermostability. The classifier models were LogisticRegression, RandomForest, SupportVector, and GradientBoosting, and classification was defined relative to the training set median of 66.29 degrees Celsius. Thus, above-threshold and below-threshold describe position in this data set, not developability. The best performing model, RandomForest, improved on recall but reduced its precision by recovering two above-threshold antibodies in return for two more false positives. False positives are preferred to false negatives and classification models tended to reduce false negative counts. Most test antibodies also share a parent with a training antibody, so the models predict well for new combinations of known parents but generalization to unknown parents remain unseen However, due to the limited data set used, independent dataset validation is needed before drawing concrete conclusions.

Authors

Publication Details

Journal
Preprints.org
Published
2026-11-02
DOI
https://doi.org/10.20944/preprints202611.0043.v1
Primary Topic
Monoclonal and Polyclonal Antibodies Research
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
preprint

Training Machine Learning Prediction of Antibody Thermostability Utilizing PROPERMAB Features and the GDPa4 Dataset

Hanna Ke, Jianghai Liu, Jenna Ke
2 links
Preprints.org
Monoclonal and Polyclonal Antibodies Research
preprint

Training Machine Learning Prediction of Antibody Thermostability Utilizing PROPERMAB Features and the GDPa4 Dataset

Hanna Ke, Jianghai Liu, Jenna Ke
preprint en

Abstract

Antibody drug development is a years-long, costly process. Antibody thermostability is one of the key developability features of an antibody drug that influences its chances of success in development. But, experimental testing such as nanoDSF for large libraries of candidates requires substantial resources. Instead, we evaluated an open-source feature-based machine learning workflow to train a model for antibody stability (Tm1) predictions from sequence and structure-based features. We used PROPERMAB to extract features from a selection of 231 different monoclonal and bispecific antibodies from the GDPa4 nanoDSF dataset. We benchmarked regression and classification models that predict the median first thermal transition temperature (Tm1) from PTS-IF in degrees Celsius for antibodies in the GDPa4 data set from Gingko Datapoints. We trained the models on 184 antibodies and evaluated model performance on 47 held-out antibodies. The three different regression models were ElasticNet, RandomForest, and GradientBoosting. RandomForest achieved the highest reported correlations among the regressors (Pearson r = 0.750, R2 = 0.562). Performance was also evaluated relative to 66.29 degrees Celsius as the threshold for thermostability. The classifier models were LogisticRegression, RandomForest, SupportVector, and GradientBoosting, and classification was defined relative to the training set median of 66.29 degrees Celsius. Thus, above-threshold and below-threshold describe position in this data set, not developability. The best performing model, RandomForest, improved on recall but reduced its precision by recovering two above-threshold antibodies in return for two more false positives. False positives are preferred to false negatives and classification models tended to reduce false negative counts. Most test antibodies also share a parent with a training antibody, so the models predict well for new combinations of known parents but generalization to unknown parents remain unseen However, due to the limited data set used, independent dataset validation is needed before drawing concrete conclusions.

Preprints.org
Good health and well-being
Monoclonal and Polyclonal Antibodies Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon